{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T23:10:48Z","timestamp":1721085048633},"reference-count":0,"publisher":"Portico","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2012.48.3.1750274","type":"journal-article","created":{"date-parts":[[2014,7,31]],"date-time":"2014-07-31T03:37:39Z","timestamp":1406777859000},"page":"177","source":"Crossref","is-referenced-by-count":4,"title":["Bosutinib for the treatment of chronic myeloid leukemia in chronic\nphase"],"prefix":"10.3730","volume":"48","author":[{"family":"Quintas-Cardama, A.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kantarjian, H.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Cortes, J.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2012]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:36:28Z","timestamp":1685453788000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddfphp"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2012.48.3.1750274","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}